CAMRESE LO Trademark

Trademark Overview

On Wednesday, February 20, 2013, a trademark application was filed for CAMRESE LO with the United States Patent and Trademark Office. The USPTO has given the CAMRESE LO trademark a serial number of 85855235. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 19, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The CAMRESE LO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health
camrese lo

General Information

Serial Number85855235
Word MarkCAMRESE LO
Filing DateWednesday, February 20, 2013
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 19, 2024
Registration Number4417937
Registration DateTuesday, October 15, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2013

Trademark Statements

Goods and ServicesPharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health
Disclaimer with Predetermined Text"LO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 27, 2013
Primary Code005
First Use Anywhere DateWednesday, December 7, 2011
First Use In Commerce DateWednesday, December 7, 2011

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Tuesday, March 19, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 19, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 19, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 16, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, October 15, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 28, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 28, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 7, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, November 22, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, November 22, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 16, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 16, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, October 15, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 15, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 25, 2013ASSIGNED TO LIE
Friday, June 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 7, 2013EXAMINER'S AMENDMENT ENTERED
Friday, June 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 7, 2013EXAMINERS AMENDMENT E-MAILED
Friday, June 7, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 4, 2013ASSIGNED TO EXAMINER
Wednesday, February 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, February 24, 2013NEW APPLICATION ENTERED

Related Keywords

camrese disorders treating conditions related health women agents hormonal oral namely